Intra-Cellular ends year with OK for schizophrenia drug lumateperoneUS biotech Intra-Cellular Therapies’ has claimed an FDA approval for schizophrenia therapy lumateperone setting up the launch of Share XIntra-Cellular ends year with OK for schizophrenia drug lumateperonehttps://pharmaphorum.com/news/intra-cellular-ends-year-with-ok-for-schizophrenia-drug-lumateperone/
